CIBC Private Wealth Group’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-72,069	Closed	-$11M	–	1106
2021 Q1	$11M	Sell	72,069 -86,368	-55%	-$13.4M	0.03%	318
2020 Q4	$24.8M	Sell	158,437 -8,051	-5%	-$1.03M	0.07%	206
2020 Q3	$19.1M	Sell	166,488 -4,529	-3%	-$489K	0.06%	212
2020 Q2	$19.2M	Buy	171,017 +31,598	+23%	+$3.35M	0.09%	151
2020 Q1	$12.5M	Buy	139,419 +1,162	+0.8%	+$114K	0.05%	219
2019 Q4	$15M	Sell	138,257 -7,414	-5%	-$793K	0.05%	238
2019 Q3	$14.3M	Sell	145,671 -3,583	-2%	-$404K	0.05%	237
2019 Q2	$19.6M	Buy	149,254 +2,217	+2%	+$286K	0.07%	207
2019 Q1	$19.9M	Buy	147,037 +76,815	+109%	+$9.55M	0.08%	196
2018 Q4	$6.84M	Sell	70,222 -173	-0.2%	-$20.4K	0.03%	307
2018 Q3	$9.79M	Buy	70,395 +59,108	+524%	+$7.41M	0.04%	301
2018 Q2	$1.4M	Sell	11,287 -61	-0.5%	-$7.13K	0.01%	587
2018 Q1	$1.26M	Buy	11,348 +47	+0.4%	+$5.62K	0.01%	602
2017 Q4	$1.35M	Sell	11,301 -28	-0.2%	-$3.41K	0.01%	599
2017 Q3	$1.59M	Buy	+11,329	New	+$1.54M	0.01%	539